Rondon E, Pirani O, SantAna De Camargo P, Leal C, Correa Filho R
Braz J Microbiol. 2023; 54(4):3321-3325.
PMID: 37919460
PMC: 10689306.
DOI: 10.1007/s42770-023-01162-4.
Hundeshagen G, Herndon D, Capek K, Branski L, Voigt C, Killion E
Crit Care. 2017; 21(1):318.
PMID: 29262848
PMC: 5738705.
DOI: 10.1186/s13054-017-1899-3.
Cartotto R
Burns Trauma. 2017; 5:33.
PMID: 29075650
PMC: 5648513.
DOI: 10.1186/s41038-017-0096-6.
Lee K, Joory K, Moiemen N
Burns Trauma. 2016; 2(4):169-80.
PMID: 27574647
PMC: 4978094.
DOI: 10.4103/2321-3868.143620.
Tiwari V
Indian J Plast Surg. 2012; 45(2):364-73.
PMID: 23162236
PMC: 3495387.
DOI: 10.4103/0970-0358.101319.
Emerging infections in burns.
Branski L, Al-Mousawi A, Rivero H, Jeschke M, Sanford A, Herndon D
Surg Infect (Larchmt). 2009; 10(5):389-97.
PMID: 19810827
PMC: 2956561.
DOI: 10.1089/sur.2009.024.
[Effector molecules of the innate immune system for treatment of wound infections].
Steinstrasser L, Langer S, Lehnhardt M, Steinau H
Chirurg. 2007; 78(4):343-8.
PMID: 17377758
DOI: 10.1007/s00104-007-1314-8.
Adenoviral gene delivery to primary human cutaneous cells and burn wounds.
Hirsch T, von Peter S, Dubin G, Mittler D, Jacobsen F, Lehnhardt M
Mol Med. 2007; 12(9-10):199-207.
PMID: 17225867
PMC: 1770006.
DOI: 10.2119/2006-00031.Hirsch.
Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.
Steinstraesser L, Tack B, Waring A, Hong T, Boo L, Fan M
Antimicrob Agents Chemother. 2002; 46(6):1837-44.
PMID: 12019098
PMC: 127209.
DOI: 10.1128/AAC.46.6.1837-1844.2002.
Absorption of toxic drugs from burns.
Br Med J. 1967; 2(5552):590.
PMID: 6026334
PMC: 1842100.
Probit analysis of burn mortality in 1,831 patients: comparison with other large series.
RITTENBURY M, Maddox R, Schmidt F, Ham Jr W, HAYNES Jr B
Ann Surg. 1966; 164(1):123-38.
PMID: 5947284
PMC: 1477183.
DOI: 10.1097/00000658-196607000-00014.
Treatment of severe burns with aqueous silver nitrate (0.5 percent).
Polk Jr H
Ann Surg. 1966; 164(4):753-70.
PMID: 5924793
PMC: 1477301.
DOI: 10.1097/00000658-196610000-00018.
Pathology of the lung in fatally burned patints.
Foley F, Moncrief J, MASON Jr A
Ann Surg. 1968; 167(2):251-64.
PMID: 5635705
PMC: 1387412.
DOI: 10.1097/00000658-196802000-00015.
Topical and systemic antibacterial agents in the treatment of burns.
Hummel R, MacMILLAN B, Altemeier W
Ann Surg. 1970; 172(3):370-84.
PMID: 5459095
PMC: 1397324.
DOI: 10.1097/00000658-197009000-00007.
Effect of current therapy on burn mortality.
SILVERSTEIN P, DRESSLER D
Ann Surg. 1970; 171(1):124-9.
PMID: 5409752
PMC: 1396577.
DOI: 10.1097/00000658-197001000-00018.
The metabolism or (35S)homosulphanilamide.
Wong L, Millburn P, Williams R
Biochem J. 1971; 124(2):17P.
PMID: 5158478
PMC: 1177183.
DOI: 10.1042/bj1240017pa.
Infection associated with burns.
Lowbury E
Postgrad Med J. 1972; 48(560):338-41.
PMID: 5049253
PMC: 2495235.
Treatment of infected surface lesions with sulfamylon acetate cream.
Holt R, Newman R, Frankcombe C
Arch Dis Child. 1972; 47(251):143-5.
PMID: 5018636
PMC: 1648005.
DOI: 10.1136/adc.47.251.143.
Control of infection with gram-negative bacteria in patients at special risk.
Lowbury E
Proc R Soc Med. 1971; 64(9):986-8.
PMID: 5000382
PMC: 1812815.
Lung bacterial clearance in the burned rat.
Skornik W, DRESSLER D
Ann Surg. 1970; 172(5):837-43.
PMID: 4991087
PMC: 1397365.
DOI: 10.1097/00000658-197011000-00008.
